{"transactions":[{"id":742234,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series D Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":464550,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":407132},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742233,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series D Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":464550,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":407132},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742232,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series C Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":246732,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":260992},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742231,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series C Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":246732,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":260992},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742230,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series B Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":143650,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":149238},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742229,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series B Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":143650,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":149238},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742228,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series A Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":166070,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":122990},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742227,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series A Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":166070,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":122990},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742226,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":407132,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":940352,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742225,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":407132,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":940352,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742224,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":260992,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":533220,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742223,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":260992,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":533220,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742222,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":149238,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":272228,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742221,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":149238,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":272228,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742220,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":122990,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":122990,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742219,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":122990,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":122990,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":875272,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":5,"value":10000000.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6207982,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":875271,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":831978,"price":5,"value":4159890.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8153107,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":875270,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":1084012,"price":5,"value":5420060.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":10622957,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":875269,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":1084010,"price":5,"value":5420050.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":10622928,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":1076729,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2025-08-04T22:28:33.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":2599932,"price":3.2,"value":8319782.4,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":7321129,"source":{"system":"sec-edgar","filing":"0001193805-25-001155","document":"e664762_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001155/e664762_4-larimar.xml","form_type":"4"}},{"id":1076728,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2025-08-04T22:28:33.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":3387539,"price":3.2,"value":10840124.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":9538945,"source":{"system":"sec-edgar","filing":"0001193805-25-001155","document":"e664762_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001155/e664762_4-larimar.xml","form_type":"4"}},{"id":1076727,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2025-08-04T22:28:33.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":3387529,"price":3.2,"value":10840092.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":9538918,"source":{"system":"sec-edgar","filing":"0001193805-25-001155","document":"e664762_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001155/e664762_4-larimar.xml","form_type":"4"}},{"id":1098456,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-07-01T20:42:51.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":370074,"price":18.46,"value":6831566.04,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.20 to $18.89, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4887254,"source":{"system":"sec-edgar","filing":"0001193805-25-000959","document":"e664668_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000959/e664668_4-arsp.xml","form_type":"4"}},{"id":1098455,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-07-01T20:42:51.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":370075,"price":18.46,"value":6831584.5,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.20 to $18.89, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4887254,"source":{"system":"sec-edgar","filing":"0001193805-25-000959","document":"e664668_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000959/e664668_4-arsp.xml","form_type":"4"}},{"id":1367220,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":9553,"price":17.77,"value":169756.81,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.69 to $17.82, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5257328,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367219,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":9554,"price":17.77,"value":169774.58,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.69 to $17.82, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5257329,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367218,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":7854,"price":17.16,"value":134774.64,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.68 to $17.65, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5266881,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367217,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":7853,"price":17.16,"value":134757.48,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.68 to $17.65, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5266883,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367216,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":223632,"price":18.15,"value":4058920.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.91 to $18.51, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5274735,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367215,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":223632,"price":18.15,"value":4058920.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.91 to $18.51, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5274736,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367214,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":40596,"price":17.45,"value":708400.2,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.90 to $17.90, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 4, 5 and 6 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5498367,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367213,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":40596,"price":17.45,"value":708400.2,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.90 to $17.90, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 4, 5 and 6 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5498368,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1639318,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2024-02-16T19:37:50.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":1430205,"price":8.74,"value":12499991.7,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4207982,"source":{"system":"sec-edgar","filing":"0001193805-24-000245","document":"e619284_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000245/e619284_4-larimar.xml","form_type":"4"}},{"id":1639317,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2024-02-16T19:37:50.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":1430206,"price":8.74,"value":12500000.44,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6151406,"source":{"system":"sec-edgar","filing":"0001193805-24-000245","document":"e619284_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000245/e619284_4-larimar.xml","form_type":"4"}},{"id":1639316,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2024-02-16T19:37:50.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":1430206,"price":8.74,"value":12500000.44,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6151389,"source":{"system":"sec-edgar","filing":"0001193805-24-000245","document":"e619284_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000245/e619284_4-larimar.xml","form_type":"4"}},{"id":1654022,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":3,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Series D Preferred Stock","published_at":"2024-02-08T19:07:12.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":164612,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (the \"Fund\"). Deerfield Management Company, L.P. is the investment manager of the Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":76706},"source":{"system":"sec-edgar","filing":"0001193805-24-000147","document":"e619233_4-flynn.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000147/e619233_4-flynn.xml","form_type":"4"}},{"id":1654021,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":3,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Series C-2 Preferred Stock","published_at":"2024-02-08T19:07:12.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1625699,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C-2 Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C-2 Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series C-2 Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series C-2 Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (the \"Fund\"). Deerfield Management Company, L.P. is the investment manager of the Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":757548},"source":{"system":"sec-edgar","filing":"0001193805-24-000147","document":"e619233_4-flynn.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000147/e619233_4-flynn.xml","form_type":"4"}},{"id":1654020,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":3,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Common Stock","published_at":"2024-02-08T19:07:12.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":76706,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (the \"Fund\"). Deerfield Management Company, L.P. is the investment manager of the Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":834254,"source":{"system":"sec-edgar","filing":"0001193805-24-000147","document":"e619233_4-flynn.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000147/e619233_4-flynn.xml","form_type":"4"}},{"id":1654019,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":3,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Common Stock","published_at":"2024-02-08T19:07:12.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":757548,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C-2 Preferred Stock automatically converted into 0.46598 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-2.146 reverse split of the Issuer's common stock effected by the Issuer on January 26, 2024)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (the \"Fund\"). Deerfield Management Company, L.P. is the investment manager of the Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":757548,"source":{"system":"sec-edgar","filing":"0001193805-24-000147","document":"e619233_4-flynn.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000147/e619233_4-flynn.xml","form_type":"4"}},{"id":2074550,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":15220,"price":0.27,"value":4109.4,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.28, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":284697,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074549,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":61826,"price":0.27,"value":16693.02,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.28, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1156308,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074548,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":61826,"price":0.27,"value":16693.02,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.28, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1156309,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074547,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":15538,"price":0.26,"value":4039.88,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.27, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":299917,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074546,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":63108,"price":0.26,"value":16408.08,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.27, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1218134,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074545,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":63107,"price":0.26,"value":16407.82,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.27, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1218135,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074544,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-28","kind":"sale","acquired":false,"shares":6096,"price":0.25,"value":1524.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.26, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":315455,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074543,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-28","kind":"sale","acquired":false,"shares":24757,"price":0.25,"value":6189.25,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.26, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1281242,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074542,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-28","kind":"sale","acquired":false,"shares":24757,"price":0.25,"value":6189.25,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.26, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1281242,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2076301,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":7136,"price":0.27,"value":1926.72,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.29, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":321551,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076300,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":28977,"price":0.27,"value":7823.79,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.29, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1305999,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076299,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":28977,"price":0.27,"value":7823.79,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.29, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1305999,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076298,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":909,"price":0.28,"value":254.52,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.29, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-2 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":328687,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076297,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":3693,"price":0.28,"value":1034.04,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.29, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-2 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1334976,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076296,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":3692,"price":0.28,"value":1033.76,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.29, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-2 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1334976,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2079078,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":1513,"price":0.3,"value":453.9,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.29 to $0.30, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":329596,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079077,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":6143,"price":0.3,"value":1842.9,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.29 to $0.30, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1338669,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079076,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":6144,"price":0.3,"value":1843.2,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.29 to $0.30, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1338668,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079075,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":1616,"price":0.31,"value":500.96,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.30 to $0.32, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":331109,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079074,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":6562,"price":0.31,"value":2034.22,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.30 to $0.32, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1344812,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079073,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":6562,"price":0.31,"value":2034.22,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.30 to $0.32, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1344812,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079072,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":10930,"price":0.29,"value":3169.7,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.30, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":332725,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079071,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":44394,"price":0.29,"value":12874.26,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.30, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1351374,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079070,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":44394,"price":0.29,"value":12874.26,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.30, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1351374,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2085584,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":339,"price":0.39,"value":132.21,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.39 to $0.41, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":343655,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085583,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":1375,"price":0.39,"value":536.25,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.39 to $0.41, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1395768,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085582,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":1375,"price":0.39,"value":536.25,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.39 to $0.41, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1395768,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085581,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":943,"price":0.38,"value":358.34,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.37 to $0.38, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":343994,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085580,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":3829,"price":0.38,"value":1455.02,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.37 to $0.38, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1397143,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085579,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":3828,"price":0.38,"value":1454.64,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.37 to $0.38, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1397143,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085578,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":230,"price":0.41,"value":94.3,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.40 to $0.42, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":344937,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085577,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":933,"price":0.41,"value":382.53,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.40 to $0.42, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1400972,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085576,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":934,"price":0.41,"value":382.94,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.40 to $0.42, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1400971,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2154360,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2022-09-21T00:31:45.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":2777777,"price":3.15,"value":8749997.55,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":2777777,"source":{"system":"sec-edgar","filing":"0001193805-22-001296","document":"e621937_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001296/e621937_4-larimar.xml","form_type":"4"}},{"id":2154359,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2022-09-21T00:31:45.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":2777777,"price":3.15,"value":8749997.55,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4721197,"source":{"system":"sec-edgar","filing":"0001193805-22-001296","document":"e621937_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001296/e621937_4-larimar.xml","form_type":"4"}},{"id":2154358,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2022-09-21T00:31:45.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":2777777,"price":3.15,"value":8749997.55,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4721200,"source":{"system":"sec-edgar","filing":"0001193805-22-001296","document":"e621937_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001296/e621937_4-larimar.xml","form_type":"4"}},{"id":2154357,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2022-09-21T00:31:45.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":2777777,"price":3.15,"value":8749997.55,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4721183,"source":{"system":"sec-edgar","filing":"0001193805-22-001296","document":"e621937_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001296/e621937_4-larimar.xml","form_type":"4"}},{"id":2215573,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Warrant to Purchase Common Stock","published_at":"2022-07-05T21:27:39.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":1889509,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved the issuance of Warrants as consideration for the execution and delivery of the Amended and Restated Credit Agreement, dated as of June 30, 2022 among the Funds (as defined below), the Issuer, and Wilmington Trust, National Association, as administrative agent for the lenders named therein, pursuant to which each Fund agreed to make, refinance or otherwise continue and/or maintain a $17.5 million ($35.0 million in the aggregate) term loan to the Issuer. The issuance of such Warrants was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1889509,"derivative":{"exercise_price":1.1114,"exercise_date":"2022-06-30","expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":1889509},"source":{"system":"sec-edgar","filing":"0001193805-22-001053","document":"e621811_4-am.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001053/e621811_4-am.xml","form_type":"4"}},{"id":2215572,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Warrant to Purchase Common Stock","published_at":"2022-07-05T21:27:39.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":1889509,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved the issuance of Warrants as consideration for the execution and delivery of the Amended and Restated Credit Agreement, dated as of June 30, 2022 among the Funds (as defined below), the Issuer, and Wilmington Trust, National Association, as administrative agent for the lenders named therein, pursuant to which each Fund agreed to make, refinance or otherwise continue and/or maintain a $17.5 million ($35.0 million in the aggregate) term loan to the Issuer. The issuance of such Warrants was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1889509,"derivative":{"exercise_price":1.1114,"exercise_date":"2022-06-30","expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":1889509},"source":{"system":"sec-edgar","filing":"0001193805-22-001053","document":"e621811_4-am.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001053/e621811_4-am.xml","form_type":"4"}},{"id":2628628,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":6,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock","published_at":"2021-07-21T21:14:17.000Z","date":"2021-07-19","kind":"purchase","acquired":true,"shares":680592,"price":14,"value":9528288.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":3438589,"source":{"system":"sec-edgar","filing":"0001193805-21-001059","document":"e620814_4-am.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001059/e620814_4-am.xml","form_type":"4"}},{"id":2628627,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":6,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock","published_at":"2021-07-21T21:14:17.000Z","date":"2021-07-19","kind":"purchase","acquired":true,"shares":390836,"price":14,"value":5471704.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1974638,"source":{"system":"sec-edgar","filing":"0001193805-21-001059","document":"e620814_4-am.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001059/e620814_4-am.xml","form_type":"4"}},{"id":2645846,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2021-07-02T21:07:18.000Z","date":"2021-06-30","kind":"purchase","acquired":true,"shares":228570,"price":8.75,"value":1999987.5,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares reported herein as being held through Deerfield Private Design Fund III, L.P. (\"Fund III\"), Deerfield Private Design Fund IV, L.P. (\"Fund IV\") and Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\" and, collectively with Fund III and Fund IV, the \"Funds\") include shares that were previously reported as being held indirectly through Chondrial Therapeutics Holdings, LLC (\"Chondrial\"), which shares were distributed to the Funds pursuant to a pro rata distribution to the members of Chondrial."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Fund III. Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt HIF, L.P. is the general partner of Deerfield HIF. Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1943420,"source":{"system":"sec-edgar","filing":"0001193805-21-000974","document":"e620772_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000974/e620772_4-larimar.xml","form_type":"4"}},{"id":2645845,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2021-07-02T21:07:18.000Z","date":"2021-06-30","kind":"purchase","acquired":true,"shares":228571,"price":8.75,"value":1999996.25,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares reported herein as being held through Deerfield Private Design Fund III, L.P. (\"Fund III\"), Deerfield Private Design Fund IV, L.P. (\"Fund IV\") and Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\" and, collectively with Fund III and Fund IV, the \"Funds\") include shares that were previously reported as being held indirectly through Chondrial Therapeutics Holdings, LLC (\"Chondrial\"), which shares were distributed to the Funds pursuant to a pro rata distribution to the members of Chondrial."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Fund III. Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt HIF, L.P. is the general partner of Deerfield HIF. Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1943423,"source":{"system":"sec-edgar","filing":"0001193805-21-000974","document":"e620772_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000974/e620772_4-larimar.xml","form_type":"4"}},{"id":2645844,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2021-07-02T21:07:18.000Z","date":"2021-06-30","kind":"purchase","acquired":true,"shares":228569,"price":8.75,"value":1999978.75,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares reported herein as being held through Deerfield Private Design Fund III, L.P. (\"Fund III\"), Deerfield Private Design Fund IV, L.P. (\"Fund IV\") and Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\" and, collectively with Fund III and Fund IV, the \"Funds\") include shares that were previously reported as being held indirectly through Chondrial Therapeutics Holdings, LLC (\"Chondrial\"), which shares were distributed to the Funds pursuant to a pro rata distribution to the members of Chondrial."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Fund III. Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt HIF, L.P. is the general partner of Deerfield HIF. Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1943406,"source":{"system":"sec-edgar","filing":"0001193805-21-000974","document":"e620772_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000974/e620772_4-larimar.xml","form_type":"4"}},{"id":2851778,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":8,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-02-18T23:44:17.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":32884,"price":19,"value":624796.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":345167,"source":{"system":"sec-edgar","filing":"0001193805-21-000245","document":"e620308_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000245/e620308_4-oncorus.xml","form_type":"4"}},{"id":2851777,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":8,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-02-18T23:44:17.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":133558,"price":19,"value":2537602.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1401905,"source":{"system":"sec-edgar","filing":"0001193805-21-000245","document":"e620308_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000245/e620308_4-oncorus.xml","form_type":"4"}},{"id":2851776,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":8,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-02-18T23:44:17.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":133558,"price":19,"value":2537602.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1401905,"source":{"system":"sec-edgar","filing":"0001193805-21-000245","document":"e620308_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000245/e620308_4-oncorus.xml","form_type":"4"}},{"id":2912788,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-01-08T22:54:08.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":101600,"price":22.2421,"value":2259797.36,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.10 to $23.07, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Management Company, L.P. is the investment manager of Fund III. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by Fund III is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":784568,"source":{"system":"sec-edgar","filing":"0001193805-21-000029","document":"e620201_4-lumos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000029/e620201_4-lumos.xml","form_type":"4"}},{"id":2912787,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-01-08T22:54:08.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":3912,"price":23.567,"value":92194.104,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.22 to $23.96, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Management Company, L.P. is the investment manager of Fund III. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by Fund III is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":886168,"source":{"system":"sec-edgar","filing":"0001193805-21-000029","document":"e620201_4-lumos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000029/e620201_4-lumos.xml","form_type":"4"}},{"id":2912786,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-01-08T22:54:08.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":1000,"price":24.108,"value":24108.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.275, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Management Company, L.P. is the investment manager of Fund III. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by Fund III is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":890080,"source":{"system":"sec-edgar","filing":"0001193805-21-000029","document":"e620201_4-lumos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000029/e620201_4-lumos.xml","form_type":"4"}},{"id":2912785,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-01-08T22:54:08.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":4378,"price":25.049,"value":109664.522,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.13, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Management Company, L.P. is the investment manager of Fund III. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by Fund III is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":891080,"source":{"system":"sec-edgar","filing":"0001193805-21-000029","document":"e620201_4-lumos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000029/e620201_4-lumos.xml","form_type":"4"}},{"id":2912784,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-01-08T22:54:08.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":11794,"price":24.3477,"value":287156.7738,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.88, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Management Company, L.P. is the investment manager of Fund III. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by Fund III is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":895458,"source":{"system":"sec-edgar","filing":"0001193805-21-000029","document":"e620201_4-lumos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000029/e620201_4-lumos.xml","form_type":"4"}},{"id":2912783,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-01-08T22:54:08.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":931,"price":22.6446,"value":21082.1226,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.56 to $22.695, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Management Company, L.P. is the investment manager of Fund III. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by Fund III is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":907252,"source":{"system":"sec-edgar","filing":"0001193805-21-000029","document":"e620201_4-lumos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000029/e620201_4-lumos.xml","form_type":"4"}},{"id":2912782,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":2,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-01-08T22:54:08.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":28108,"price":22.4712,"value":631620.4896,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.565 to $22.55, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 4, 5, 6, 7, 8 and 9 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Management Company, L.P. is the investment manager of Fund III. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by Fund III is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":908183,"source":{"system":"sec-edgar","filing":"0001193805-21-000029","document":"e620201_4-lumos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000029/e620201_4-lumos.xml","form_type":"4"}},{"id":3010315,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":8,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Series B Preferred Stock","published_at":"2020-10-08T21:31:05.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":2449761,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":202670},"source":{"system":"sec-edgar","filing":"0001193805-20-001260","document":"e619992_4-oncorus.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380520001260/e619992_4-oncorus.xml","form_type":"4"}},{"id":3010314,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":8,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Series B Preferred Stock","published_at":"2020-10-08T21:31:05.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":2449761,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":202670},"source":{"system":"sec-edgar","filing":"0001193805-20-001260","document":"e619992_4-oncorus.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380520001260/e619992_4-oncorus.xml","form_type":"4"}},{"id":3010313,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":8,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Series B Preferred Stock","published_at":"2020-10-08T21:31:05.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":2449761,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":202670},"source":{"system":"sec-edgar","filing":"0001193805-20-001260","document":"e619992_4-oncorus.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380520001260/e619992_4-oncorus.xml","form_type":"4"}},{"id":3010312,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":8,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Series A-1 Preferred Stock","published_at":"2020-10-08T21:31:05.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":7499999,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-1 Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-1 Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-1 Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-1 Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":620480},"source":{"system":"sec-edgar","filing":"0001193805-20-001260","document":"e619992_4-oncorus.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380520001260/e619992_4-oncorus.xml","form_type":"4"}},{"id":3010311,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":8,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Series A-1 Preferred Stock","published_at":"2020-10-08T21:31:05.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":7499999,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-1 Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-1 Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-1 Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-1 Preferred Stock automatically converted into 0.0827 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-12.0874 reverse stock split effected by the Issuer on September 25, 2020)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":620480},"source":{"system":"sec-edgar","filing":"0001193805-20-001260","document":"e619992_4-oncorus.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380520001260/e619992_4-oncorus.xml","form_type":"4"}},{"id":3010310,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":8,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2020-10-08T21:31:05.000Z","date":"2020-10-06","kind":"purchase","acquired":true,"shares":109612,"price":15,"value":1644180.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":312282,"source":{"system":"sec-edgar","filing":"0001193805-20-001260","document":"e619992_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380520001260/e619992_4-oncorus.xml","form_type":"4"}}],"next_cursor":"2020-10-08T21:31:05.000000Z,3010310"}